flurbiprofen and Fibrosis, Inflammatory Perianeurysmal studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

Excerpt	Relevance	Reference
"The case of vasomotor parenchymal acute renal failure is reported in a patient a few days after the initiation of treatment by Enalapril which is a new converting enzyme inhibitor."	5.27	[Acute renal insufficiency caused by observed a combination of enalapril, furosemide and flurbiprofen in a patient with retroperitoneal fibrosis]. ( Coevoet, B; Demontis, R; Fournier, A; Guellal, A, 1987)
"The case of vasomotor parenchymal acute renal failure is reported in a patient a few days after the initiation of treatment by Enalapril which is a new converting enzyme inhibitor."	1.27	[Acute renal insufficiency caused by observed a combination of enalapril, furosemide and flurbiprofen in a patient with retroperitoneal fibrosis]. ( Coevoet, B; Demontis, R; Fournier, A; Guellal, A, 1987)

Research

Studies (1)

Authors

Other Studies

1 other study available for flurbiprofen and Fibrosis, Inflammatory Perianeurysmal

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80